Colorectal Cancer Treatment in Lucknow
Expert Care at Lucknow Cancer Institute
Colorectal cancer is the third most common cancer worldwide and ranks fourth in India. With rising incidence linked to westernized diets and urbanization, early detection through screening is crucial for improving survival rates. Dr. Sidharth Pant provides comprehensive colorectal cancer management including surgery coordination, chemotherapy, targeted therapy, and personalized treatment plans.
Colorectal Cancer Epidemiology
Understanding the global and Indian burden of colorectal cancer
Global Epidemiology
- Third most common cancer worldwide
- 1.93 million new cases and 930,000 deaths in 2020
- Projected to reach 3.2 million new cases by 2040
- Highest incidence in Australia/New Zealand and Europe (30–40 per 100,000)
- Lowest incidence in Africa and South Asia
- Primarily affects high HDI (Human Development Index) countries
Indian Scenario
- Ranks 4th in incidence for both sexes
- 64,863 new cases in 2022 (40,430 males, 24,433 females)
- 38,367 deaths in 2022
- Age-adjusted rates: 5.7 per 100,000 males, 3.4 per 100,000 females
- Incidence rose 20% from 2004–2014 (5.8 to 6.9 per 100,000)
- Continuing upward trend in urban areas
Regional Trends in India
- Chennai: 35% increase in incidence
- Delhi: 32% increase in incidence
- Northeast India: High incidence in Aizawl, Kamrup Urban
- Urban areas: Higher rates due to lifestyle changes
- Projected doubling of cases by 2050
- Linked to westernized diets and urbanization
Key Insights
- Significant rise in Indian urban centers
- Earlier age at diagnosis compared to West
- Strong association with dietary changes
- Screening can reduce mortality by 30-40%
- Early detection dramatically improves survival
- Preventable through lifestyle modifications
Risk Factors & Prevention
Understanding and preventing colorectal cancer
Dietary Factors
Major Dietary Risks:
- Red and processed meat: High consumption increases risk
- Low fiber intake: Insufficient dietary fiber
- Low fruit/vegetable consumption: Reduced protective benefits
- High-fat diets: Especially saturated fats
- Westernized diets: Calorie-rich, low-fiber patterns
Lifestyle Factors
Modifiable Risk Factors:
- Obesity: Particularly abdominal obesity
- Sedentary behavior: Physical inactivity
- Smoking: Tobacco use increases risk
- Alcohol consumption: Regular heavy drinking
- Type 2 diabetes: Associated with increased risk
Medical & Genetic Factors
Non-Modifiable Risk Factors:
- Inflammatory Bowel Disease (IBD): Crohn's, ulcerative colitis
- Colon polyps: Adenomatous polyps precursor
- Family history: First-degree relatives with CRC
- Genetic syndromes: Lynch syndrome, FAP
- Age: Risk increases after 50 years
Prevention Strategies
Effective Prevention Measures:
- Regular screening: Starting at age 50
- High-fiber diet: Fruits, vegetables, whole grains
- Limit red/processed meat: Moderate consumption
- Regular exercise: 150 minutes weekly
- Maintain healthy weight: BMI 18.5-24.9
- Limit alcohol: Moderation is key
- No smoking: Tobacco cessation
Rising Trend in India
Colorectal cancer incidence is rising rapidly in Indian urban areas due to urbanization, calorie-rich/low-fiber diets, and sedentary lifestyles. Early screening and lifestyle modifications are crucial for prevention.
Types & Staging
Understanding colorectal cancer classification and staging
Types of Colorectal Cancer
Adenocarcinoma (80-90%)
Most common type, develops from glandular cells lining the colon/rectum
Colon Cancer Locations
Proximal Colon
Right side, ascending colon
Distal Colon
Left side, descending colon
Rectal Cancer
Cancer of the rectum, often treated differently from colon cancer
Rare Types (5-10%)
- Carcinoid tumors
- Gastrointestinal stromal tumors (GIST)
- Lymphomas
- Sarcomas
Staging & Survival Rates
Staging Systems
Colorectal cancer is staged using TNM system (Tumor, Nodes, Metastasis) and traditional Dukes classification. Accurate staging guides treatment decisions and predicts prognosis.
Symptoms & Diagnosis
Recognizing warning signs and comprehensive diagnostic approach
Warning Signs & Symptoms
Early Stage (Often Asymptomatic):
No specific symptoms - screening is crucial for early detection
May have subtle changes in bowel habits
Advanced Stage Symptoms:
Blood in Stool
Visible or occult blood
Weight Loss
Unexplained weight loss
Bowel Changes
Persistent diarrhea/constipation
Anemia
Fatigue, weakness, pallor
Abdominal Pain
Cramps, bloating, discomfort
Narrow Stools
Pencil-thin stools
When to Seek Medical Attention
Any persistent change in bowel habits, blood in stool, or unexplained weight loss requires immediate evaluation. Early diagnosis significantly improves treatment outcomes.
Diagnostic Pathway
Clinical Evaluation
History, physical exam, digital rectal exam
Colonoscopy + Biopsy
Gold standard for diagnosis and tissue sampling
Imaging Studies
CT/MRI for staging, PET-CT if metastatic
Laboratory Tests
CEA tumor marker, CBC, liver function tests
Molecular Testing
MSI/MMR testing, RAS/BRAF mutation analysis
Key Diagnostic Tests:
CEA Marker
Carcinoembryonic antigen for monitoring
MSI Testing
Microsatellite instability for immunotherapy
RAS/BRAF
Mutation analysis for targeted therapy
Imaging
Accurate staging for treatment planning
Personalized Treatment by Stage
Stage-specific treatment strategies for optimal outcomes
Stage I‑II
Primary Treatment:
- Surgery: Colectomy (partial or total)
- Minimally invasive: Laparoscopic or robotic surgery
- Adjuvant chemotherapy: For high-risk stage II
- Regular surveillance: Colonoscopy post-surgery
Surgical Options:
- Right/left hemicolectomy
- Low anterior resection (rectal cancer)
- Abdominoperineal resection (low rectal)
- Local excision for early rectal cancer
Stage III
Standard Treatment:
- Neoadjuvant therapy: Chemo/radiation for rectal cancer
- Surgery: Radical resection with lymph node removal
- Adjuvant chemotherapy: FOLFOX or CAPOX regimen
- Targeted therapy: Based on molecular markers
Rectal Cancer Specific:
- Total neoadjuvant therapy (TNT)
- Short-course radiation therapy
- Watch-and-wait approach in selected cases
- Sphincter preservation when possible
Stage IV
Systemic Therapy First:
- Chemotherapy: FOLFOX, FOLFIRI, CAPOX
- Targeted therapy: Anti‑EGFR (cetuximab), anti‑VEGF (bevacizumab)
- Immunotherapy: Pembrolizumab for MSI‑high/dMMR tumors
- Combination therapy: Based on molecular profile
Metastasis-Directed Therapy:
- Liver metastasis: Resection, ablation, SBRT
- Lung metastasis: Resection, SBRT
- Peritoneal metastasis: HIPEC in selected cases
- Palliative surgery for obstruction/bleeding
Modern Treatment Approaches
Advanced therapies for colorectal cancer
Chemotherapy Regimens
FOLFOX
Folinic acid + Fluorouracil + Oxaliplatin
Standard adjuvant and metastatic therapy
FOLFIRI
Folinic acid + Fluorouracil + Irinotecan
For metastatic disease, often with targeted agents
CAPOX
Capecitabine + Oxaliplatin
Oral alternative to FOLFOX
FOLFOXIRI
Intensive triple-drug regimen
For fit patients with extensive disease
Targeted & Immunotherapy
Anti‑VEGF Therapy
- Bevacizumab: First-line with chemotherapy
- Aflibercept: Second-line option
- Ramucirumab: Anti‑VEGFR2 antibody
Anti‑EGFR Therapy
- Cetuximab: For RAS/BRAF wild-type
- Panitumumab: Fully human anti‑EGFR
- Requires RAS/BRAF mutation testing
Immunotherapy
- Pembrolizumab: For MSI‑high/dMMR tumors
- Nivolumab ± ipilimumab: For MSI‑high metastatic CRC
- MSI testing essential for selection
Molecular Testing & Precision Medicine
MSI/MMR Testing
Essential for immunotherapy eligibility
15% of colorectal cancers are MSI‑high
RAS/BRAF Mutation
Guides anti‑EGFR therapy use
BRAF V600E indicates poor prognosis
HER2 Amplification
Targetable with anti‑HER2 therapy
3-5% of metastatic colorectal cancers
NTRK Fusions
Rare but targetable with larotrectinib/entrectinib
Comprehensive genomic profiling needed
Precision Medicine
Molecular testing is now standard for all metastatic colorectal cancers. Targeted therapies based on molecular profile can significantly improve outcomes with fewer side effects.
Supportive & Palliative Care
Palliative Procedures
- Colonic stenting for obstruction
- Radiation for bleeding/pain
- Surgical bypass procedures
- Management of ascites
Symptom Management
- Nutritional support
- Pain management
- Bowel regimen management
- Psychosocial support
Quality of Life Focus
- Ostomy care and support
- Sexual health counseling
- Support groups
- Advance care planning